Innovative drug design

Structure based in silico drug design became widely used in the past dedicate but it was not often employed in the real life, i.e. from the big pharma companies. This has been changed during the last year by the introduction of FEP+ technology by Schrödinger. Many projects are under development now in which most of the big pharmaceutical companies were involved. In this way, many other structure based in silico approaches became also well recognized. The main reason for this progress is the new computation capability and in particular the use of modern GPUs instead CPUs for the calculations, which makes possible an acceleration of about 30-100 times. Unfortunately, although the cosmetics active substance and drug discovery are similar in their initial phase the structure based in silico design is rare used by cosmetics companies.

MORE INFORMATION ABOUT OUR INNOVATIVE DRUG DESIGN

Our Technology is not just what it looks like and feels like. Technology is how it works revolutionally. - Dimitar Dimitrov